Have a personal or library account? Click to login
Diagnostic accuracy of (1→3)-β-D-glucan to predict Pneumocystis jirovecii pneumonia in non-HIV-infected patients Cover

Diagnostic accuracy of (1→3)-β-D-glucan to predict Pneumocystis jirovecii pneumonia in non-HIV-infected patients

By: Petra Rogina and  Miha Skvarc  
Open Access
|May 2020

References

  1. Tamburrini E, Mencarini P, Visconti E, Zolfo M, De Luca A, Siracusano A, et al. Detection of Pneumocystis carinii DNA in blood by PCR is not of value for diagnosis of P. carinii pneumonia. J Clin Microbiol 1996; 34: 1586-8. PMID: 8735128
  2. Maschmeyer G, Helweg-Larsen J, Pagano L, Robin C, Cordonnier C, Schellongowski P, et al. ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients. J Antimicrob Chemother 2016; 71: 2405-13. doi: 10.1093/jac/dkw158
  3. Maertens J, Cesaro S, Maschmeyer G, Einsele H, Donnelly JP, Alanio A, et al. ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients. J Antimicrob Chemother 2016; 71: 2397-404. doi: 10.1093/jac/dkw157.
  4. Wang J, Gigliotti F, Maggirwar S, Johnston C, Finkelstein JN, Wright TW. Pneumocystis carinii activates the NF-kappaB signaling pathway in alveolar epithelial cells. Infect Immun 2005; 73: 2766-77. doi: 10.1128/IAI.73.5.2766-2777.2005
  5. Vassallo R, Standing JE, Limper AH. Isolated Pneumocystis carinii cell wall glucan provokes lower respiratory tract inflammatory responses. J Immunol 2000; 164: 3755-63. doi: 10.4049/jimmunol.164.7.3755
  6. Tasaka S, Hasegawa N, Kobayashi S, Yamada W, Nishimura T, Takeuchi T, et al. Serum indicators for the diagnosis of Pneumocystis pneumonia. Chest 2007; 131: 1173-80. doi: 10.1378/chest.06-1467
  7. Cuetara MS, Alhambra A, Chaves F, Moragues MD, Ponton J, del Palacio A. Use of a serum (1→3)-β-D-glucan assay for diagnosis and follow-up of Pneumocystis jiroveci pneumonia. Clin Infect Dis 2008; 47: 1364-6. doi: 10.1086/592753
  8. Persat F, Ranque S, Derouin F, Michel-Nguyen A, Picot S, Sulahian A. Contribution of the (1→3)-β-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 2008; 46: 1009-13. doi: 10.1128/JCM.02091-07
  9. Pisculli ML, Sax PE. Use of a serum β-glucan assay for diagnosis of HIV-related Pneumocystis jiroveci pneumonia in patients with negative microscopic examination results. Clin Infect Dis 2008; 46: 1928-30. doi: 10.1086/588564
  10. Desmet S, Van Wijngaerden E, Maertens J, Verhaegen J, Verbeken E, De Munter P, et al. Serum (1–3)-β-D-glucan as a tool for diagnosis of Pneumocystis jirovecii pneumonia in patients with human immunodeficiency virus infection or hematological malignancy. J Clin Microbiol 2009; 47: 3871-4. doi: 10.1128/JCM.01756-09
  11. Held J, Koch M, Reischl U, Danner T, Serr A. Serum (1→3)-β-D-glucan measurement as early indicator for Pneumocystis jirovecii pneumonia and evaluation of its prognostic value. Clin Microbiol Infect 2011; 17: 595-602. doi: 10.1111/j.1469-0691.2010.03318.x
  12. Finkelman MA. Pneumocystis jirovecii infection: cell wall (1→3)-β-D-glucan biology and diagnostic utility. Crit Rev Microbiol 2010; 36: 271-81. doi: 10.3109/1040841X.2010.484001
  13. Karageorgopoulos DE, Qu JM, Korbila IP, Zhu YG, Vasileiou VA, Falagas ME. Accuracy of β-D-glucan for the diagnosis of Pneumocystis jirovecii pneumonia: a meta-analysis. Clin Microbiol Infect 2013; 19: 39-49. doi: 10.1111/j.1469-0691.2011.03760.x
  14. Wood BR, Komarow L, Zolopa AR, Finkelman MA, Powderly WG, Sax PE. Test performance of blood beta-glucan for Pneumocystis jirovecii pneumonia in patients with AIDS and respiratory symptoms. AIDS 2013; 27: 967-72. doi: 10.1097/QAD.0b013e32835cb646
  15. Sax PE, Komarow L, Finkelman MA, Grant PM, Andersen J, Scully E, et al. Blood (1→3)-β-D-glucan as a diagnostic test for HIV-related Pneumocystis jirovecii pneumonia. Clin Infect Dis 2011; 53: 197-202. doi: 10.1093/cid/ cir335
  16. Alanio A, Desoubeaux G, Sarfati C, Hamane S, Bergeron A, Azoulay E, et al. Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients. Clin Microbiol Infect 2011; 17: 1531-7. doi: 10.1111/j.1469-0691.2010.03400.x
  17. Morris A, Wei K, Afshar K, Huang L. Epidemiology and clinical significance of pneumocystis colonization. J Infect Dis 2008; 197: 10-7. doi: 10.1086/523814
  18. Can H, Caner A, Döşkaya M, Değirmenci A, Karaçalı S, Polat C, et al. Detection of Pneumocystis in the nasal swabs of immune-suppressed rats by use of PCR and microbiology. Med Sci Monit Basic Res 2013; 19: 62-7. doi: 10.12659/MSMBR.883777.
  19. Spencer L, Ukwu M, Alexander T, Valadez K, Liu L, Frederick T, et al. Epidemiology of Pneumocystis colonization in families. Clin Infect Dis 2008; 46: 1237-40. doi: 10.1086/533449
  20. Turner D, Schwarz Y, Yust I. Induced sputum for diagnosing Pneumocystis carinii pneumonia in HIV patients: new data, new issues. Eur Respir J 2003; 21: 204-8. doi: 10.1183/09031936.03.00035303
  21. Damiani C, Le Gal S, Da Costa C, Virmaux M, Nevez G, Totet A. Combined quantification of pulmonary Pneumocystis jirovecii DNA and serum (1->3)-β-D-glucan for differential diagnosis of pneumocystis pneumonia and Pneumocystis colonization. J Clin Microbiol 2013; 51: 3380-8. doi: 10.1128/JCM.01554-13
  22. Nevez G, Totet A, Pautard JC, Raccurt C. Pneumocystis carinii detection using nested-PCR in nasopharyngeal aspirates of immunocompetent infants with bronchiolitis. J Eukaryot Microbiol 2001; 48(1 Suppl): 122S-3S. doi: 10.1111/j.1550-7408.2001.tb00479.x
  23. Totet A, Meliani L, Lacube P, Pautard JC, Raccurt C, Roux P, et al. Immunocompetent infants as a human reservoir for Pneumocystis jirovecii rapid screening by non-invasive sampling and real-time PCR at the mitochondrial large subunit rRNA gene. J Eukaryot Microbiol 2003; 50(Suppl): 668-9. doi: 10.1111/j.1550-7408.2003.tb00678.x
  24. Flori P, Bellete B, Durand F, Raberin H, Cazorla C, Hafid J, et al. Comparison between real-time PCR, conventional PCR and different staining techniques for diagnosing Pneumocystis jiroveci pneumonia from bronchoalveolar lavage specimens. J Med Microbiol 2004; 53: 603-7. doi: 10.1099/ jmm.0.45528-0
  25. Fan LC, Lu HW, Cheng KB, Li HP, Xu JF. Evaluation of PCR in bronchoalveolar lavage fluid for diagnosis of Pneumocystis jiroveciii pneumonia: a bivariate meta-analysis and systematic review. PloS one 2013; 8: e73099. doi: 10.1371/journal.pone.0073099
  26. Matsumura Y, Ito Y, Iinuma Y, Yasuma K, Yamamoto M, Matsushima A, et al. Quantitative real-time PCR and the (1→3)-β-D-glucan assay for differentiation between Pneumocystis jirovecii pneumonia and colonization. Clin Microbiol Infect 2012; 18: 591-7. doi: 10.1111/j.1469-0691.2011.03605.x
  27. Damiani C, Le Gal S, Lejeune D, Brahimi N, Virmaux M, Nevez G, et al. Serum (1→3)-β-D-glucan levels in primary infection and pulmonary colonization with Pneumocystis jiroveciiJ Clin Microbiol 2011; 49: 2000-2. doi: 10.1128/ JCM.00249-11
  28. Desoubeaux G, Chesnay A, Mercier V, Bras-Cachinho J, Moshiri P, Eymieux S, et al. Combination of β-(1, 3)-D-glucan testing in serum and qPCR in nasopharyngeal aspirate for facilitated diagnosis of Pneumocystis jirovecii pneumonia. Mycoses 2019; 62: 1015-22. doi: 10.1111/myc.12997
  29. Corsi-Vasquez G, Ostrosky-Zeichner L, Pilkington EF 3rd, Sax PE. Point-counterpoint: should serum β-d-Glucan testing be used for the diagnosis of Pneumocystis jirovecii pneumonia? J Clin Microbiol 2019; 58: pii: e01340-19. doi: 10.1128/JCM.01340-19
  30. Azoulay E, Bergeron A, Chevret S, Bele N, Schlemmer B, Menotti J. Polymerase chain reaction for diagnosing pneumocystis pneumonia in non-HIV immunocompromised patients with pulmonary infiltrates. Chest 2009; 135: 655-61. doi: 10.1378/chest.08-1309
  31. Jarboui MA, Sellami A, Sellami H, Cheikhrouhou F, Makni F, Ben Arab N, et al. Molecular diagnosis of Pneumocystis jirovecii pneumonia in immunocompromised patients. Mycoses 2010; 53: 329-33. doi: 10.1111/j.1439-0507.2009.01715.x
  32. Carmona EM, Limper AH. Update on the diagnosis and treatment of Pneumocystis pneumonia. Ther Adv Respir Dis 2011; 5: 41-59. doi: 10.1177/1753465810380102
  33. Nevez G, Raccurt C, Jounieaux V, Dei-Cas E, Mazars E. Pneumocystosis versus pulmonary Pneumocystis carinii colonization in HIV-negative and HIV-positive patients. AIDS 1999; 13: 535-6. doi: 10.1097/00002030199903110-00020
  34. Huang L, Crothers K, Morris A, Groner G, Fox M, Turner JR, et al. Pneumocystis colonization in HIV-infected patients. J Eukaryot Microbiol 2003; 50(Suppl): 616-7. doi: 10.1111/j.1550-7408.2003.tb00651.x
  35. Vargas SL, Pizarro P, Lopez-Vieyra M, Neira-Avile´s P, Bustamante R, Ponce CA. Pneumocystis colonization in older adults and diagnostic yield of single versus paired noninvasive respiratory sampling. Clin Infect Dis 2010; 50: e19-e21. doi: 10.1086/649869
  36. Montesinos I, Brancart F, Schepers K, Jacobs F, Denis O, Delforge ML. Comparison of 2 real-time PCR assays for diagnosis of Pneumocystis jirovecii pneumonia in human immunodeficiency virus (HIV) and non-HIV immunocompromised patients. Diagn Microbiol Infect Dis 2015; 82: 143-7. doi: 10.1016/j.diagmicrobio.2015.03.006
  37. Fauchier T, Hasseine L, Gari-Toussaint M, Casanova V, Marty PM, Pomares C. Detection of Pneumocystis jirovecii by quantitative PCR to differentiate colonization and pneumonia in Immunocompromised HIV-positive and HIV-negative patients. J Clin Microbiol 2016; 54: 1487-95. doi: 10.1128/ JCM.03174-15
  38. Mühlethaler K, Bögli-Stuber K, Wasmer S, von Garnier C, Dumont P, Rauch A, et al. Quantitative PCR to diagnose Pneumocystis pneumonia in immunocompromised non-HIV patients. Eur Respir J 2012; 39: 971-8. doi: 10.1183/09031936.00095811
  39. Robert-Gangneux F, Belaz S, Revest M, Tattevin P, Jouneau S, Decaux O, et al. Diagnosis of Pneumocystis jirovecii pneumonia in immunocompromised patients by real-time PCR: a 4-year prospective study. J Clin Microbiol 2014; 52: 3370-6. doi: 10.1128/JCM.01480-14.
  40. Botterel F, Cabaret O, Foulet F, Cordonnier C, Costa JM, Bretagne S. Clinical significance of quantifying Pneumocystis jirovecii DNA by using real-time PCR in bronchoalveolar lavage fluid from immunocompromised patients. J Clin Microbiol 2012; 50: 227-31. doi: 10.1128/JCM.06036-11
  41. Larsen HH, Huang L, Kovacs JA, Crothers K, Silcott VA, Morris A, et al. A prospective, blinded study of quantitative touch-down polymerase chain reaction using oralwash samples for diagnosis of Pneumocystis pneumonia in HIV-infected patients. J Infect Dis 2004; 189: 1679-83. doi: 10.1086/383322
  42. Huggett JF, Taylor MS, Kocjan G, Evans HE, Morris-Jones S, Gant V, et al. Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii DNA in bronchoalveolar lavage fluid of HIV-infected patients. Thorax 2008; 63: 154-9. doi: 10.1136/thx.2007.081687
DOI: https://doi.org/10.2478/raon-2020-0028 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 221 - 226
Submitted on: Dec 31, 2019
|
Accepted on: Apr 14, 2020
|
Published on: May 28, 2020
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 Petra Rogina, Miha Skvarc, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.